Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [(68)Ga]PSMA-PET-guided metastasis-directed therapy
接受[(68)Ga]PSMA-PET引导的转移灶靶向治疗后,寡复发性前列腺癌患者的生化复发无进展生存期预后风险分级
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-020-04760-8
Vogel, Marco M E; Kroeze, Stephanie G C; Henkenberens, Christoph; Schmidt-Hegemann, Nina-Sophie; Kirste, Simon; Becker, Jessica; Burger, Irene A; Derlin, Thorsten; Bartenstein, Peter; Mix, Michael; la Fougère, Christian; Eiber, Matthias; Christiansen, Hans; Belka, Claus; Grosu, Anca L; Müller, Arndt-Christian; Guckenberger, Matthias; Combs, Stephanie E